Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies
Mawadda Chukr, Student at Aleppo University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cytokine, adding:
“My first publication is officially out in Q1
We looked at novel therapies (SYK, FcRn, and BTK inhibitors) for adult Immune Thrombocytopenia (ITP) through a systematic review and meta-analysis of 10 RCTs.
I am so grateful to my co-authors for this amazing collaboration.
Check out the graphic below for our key highlights, or read the full paper via the link!”
Title: Efficacy and safety of IgG-pathway inhibitors in adult immune thrombocytopenia: A systematic review and meta-analysis with subgroup analyses of FcRn and SYK inhibitors
Authors: Mousa Almasalma, Ahmed Hamdy Kandil, Mahmoud Hashem Al-Qadi, Mohamed Lotfy Maarouf, Sara Mohammad Altaamreh, Weaam A. Soliman, Ahmed S. Mohamed, Ahmed Boshta, Nereen A. Almosilhy, Bashar Zahir Alsalhen, Mawadda Chukr
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 18, 2026, 19:49Ana Rita Santos: Cost-Effectiveness of Chatbot-Supported Remote Monitoring for Anticoagulation Management
-
Jun 18, 2026, 19:46Angela Fan: Highlighting the Significant Burden Faced by Patients Living With PV
-
Jun 18, 2026, 15:29Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
-
Jun 18, 2026, 15:13Youssef Afifi: The Thrombocytosis–Bleeding Paradox
-
Jun 18, 2026, 15:06Nihala Sharin E A: The Vital Role of Hematology in the Medical Laboratory
-
Jun 18, 2026, 14:59Maeve Crowley: Shining a Light on Venous Thromboembolism Trends in Ireland
-
Jun 18, 2026, 14:52Samwel Mikaye: Why Early Recognition of Pulmonary Embolism Matters
-
Jun 18, 2026, 14:34Alec van Gelder: From Crisis Care to Continuous Care in SCD
-
Jun 18, 2026, 14:33Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE